Skip to main content

A Class II Medical Device Recall for 3M Bair Hugger System

A Class II Medical Device Recall for 3M Bair Hugger System

A Class II Medical Device Recall for 3M Bair Hugger System

Introduction

While preparations are in full swing for the first bellwether trial for 3M Bair Hugger System lawsuits, scheduled to begin in April 2018, there comes a Class II Recall as categorized by the FDA for the forced air warming blankets belonging to the following lot numbers: R10359, R10360, R10361, R10362, R10363, R10364, R10365, and R10366. The recall was made by the company after design defects were noticed which would prevent the affected blankets from warming patients during surgical procedures. More than 33,000 cases (each containing 5 units), sold worldwide are expected to be returned.

This recall does involve concerns about the airflow design but seems unrelated to the 3M infection cases which are consolidated in the District of Minnesota as MDL 2666- (In Re: Bair Hugger Forced Air Warming Devices Products Liability Litigation) before United States District Judge Joan N. Ericksen.

The court documents indicate more than 4,200 Bair Hugger lawsuits are pending which are filed on behalf of plaintiffs who developed serious and debilitating deep joint infections, allegedly related to the use of 3M’s forced-air warming blankets during their hip or knee replacement surgery.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!